Results 31 to 40 of about 7,629 (157)

Phytotherapy of Vulvovaginal Candidiasis: A Narrative Review. [PDF]

open access: goldInt J Mol Sci
Picheta N   +5 more
europepmc   +3 more sources

The clinical efficacy of fluconazole in the treatment of vulvovaginal candidiasis

open access: yesМедицинский совет, 2016
The article tells about the key problems of diagnosis and treatment of patients with vulvovaginal candidiasis (VVC). Candida albicans causes 75--80% of candidiasis cases.
V. N. Serov   +3 more
doaj   +1 more source

Protective efficacy of the pan-fungal vaccine NXT-2 against vulvovaginal candidiasis in a murine model [PDF]

open access: goldNPJ Vaccines
Wychrij D   +7 more
europepmc   +3 more sources

Vulvovaginal candidiasis: etiology, pathogenesis, diagnosis, treatment

open access: yesМедицинский совет, 2019
The article represents the main problems of diagnosis and treatment of patients with vulvovaginal candidiasis (VVC). It is noted that C. albicans causes candidiasis in 75-80% of cases.
N. A. Buralkina, O. V. Shabalova
doaj   +1 more source

Long‐term safety and efficacy of secukinumab in paediatric severe plaque psoriasis: 236‐week, Phase 3 trial results

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In this Phase III study, secukinumab demonstrated sustained efficacy and a favourable safety profile in paediatric patients with chronic severe plaque psoriasis over a treatment period of 236 weeks. Abstract Background Plaque psoriasis, a chronic inflammatory disease, affects up to 2.1% of the global paediatric population.
Andrzej Kaszuba   +11 more
wiley   +1 more source

Effective treatment for vulvovaginal candidiasis: case reports [PDF]

open access: yesРМЖ. Мать и дитя, 2019
Effective treatment for vulvovaginal candidiasis: case reports A.L. Tikhomirov1, S.I. Sarsaniya2 1A.I. Evdokimov Moscow University of Medicine and Dentistry, Moscow, Russian Federation 2LLC “S-Mariya”, Moscow, Russian Federation Treatment ...
Tikhomirov A.L., Sarsaniya S.I.
doaj  

Efficacy of metronidazole and miconazole vaginal co-formulation for bacterial vaginosis and vulvovaginal candidiasis [PDF]

open access: yesРМЖ. Мать и дитя, 2020
E.A. Markova Pirogov Russian National Research Medical University, Moscow, Russian Federation Recurrent vulvovaginal infections being an epidemiological and clinical issue also have social and psychological implications.
E.A. Markova
doaj  

Preserving reproductive health before the first pregnancy

open access: yesРепродуктивная эндокринология, 2022
Research objective: to evaluate the effectiveness of drugs based on decamethoxine for the treatment of inflammatory diseases of genital organs in adolescent girls entering reproductive age. Materials and methods. The study included 96 patients aged 17–19
О.V. Kravchenko
doaj   +1 more source

Effects of Video‐Based Health Education on Birth Outcomes and Anaemia Status of Mothers in Dirashe District South Ethiopia: A Cluster Randomized Controlled Trial

open access: yesMaternal &Child Nutrition, EarlyView.
ABSTRACT Undernutrition and infections during pregnancy result in low birth weight (LBW) and maternal anaemia. Social behaviour change communication (SBCC) can promote recommended health practices, potentially improving maternal and neonatal outcomes.
Wanzahun Godana Boynito   +9 more
wiley   +1 more source

Sertaconazole in the treatment of vulvovaginal candidiasis

open access: yesМедицинский совет, 2019
Vulvovaginal candidiasis today is one of the most pressing problems in the field of women’s health. However, the prevalence of Candida with formed drug resistance to fluconazole significantly complicates the treatment of this disease.
Z. N. Efendieva
doaj   +1 more source

Home - About - Disclaimer - Privacy